| Stage | EOG | % of rev | AMPY | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $8.6B | 100.00% | $53M | 100.00% | EOG ×162.51 |
| Gross profit | $7.4B | 86.65% | $52M | 98.70% | AMPY +12.1pp |
| Operating income | $3.5B | 41.21% | $23M | 44.12% | AMPY +2.9pp |
| Pre-tax income | $3.5B | 40.87% | $23M | 44.03% | AMPY +3.2pp |
| Net income | $2.7B | 31.81% | $17M | 32.83% | AMPY +1.0pp |
| Stage | EOG | AMPY | Gap · A − B |
|---|---|---|---|
| Revenue | $8.6B100.00% | $53M100.00% | EOG ×162.51 |
| Gross profit | 86.65%$7.4B | 98.70%$52M | AMPY +12.1pp |
| Operating income | 41.21%$3.5B | 44.12%$23M | AMPY +2.9pp |
| Pre-tax income | 40.87%$3.5B | 44.03%$23M | AMPY +3.2pp |
| Net income |
| 31.81%$2.7B |
| 32.83%$17M |
| AMPY +1.0pp |
No shared counterparties.